FDA Investigator Steve Y Rhieu, PhD
Steve Y Rhieu, PhD has inspections in 4 countries as of 17 Feb 2023. Steve Y Rhieu, PhD has collaborated with a combined 1075 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
17 Feb 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Spain,
Italy,
Switzerland
Co-Investigator(s):
Alan P Kurtzberg,
Anita Narula, PhD,
Chani Broner, PhD,
Cheryl A Clausen,
Chhaya S Shetty,
Cynthia Jim, CSO,
Edmund F Mrak, Jr,
Erik W Koester,
Erika V Butler,
Esther C Broner, PhD,
Gerard T Schneider,
Ginger M Sykes,
Grace E Mcnally,
Gwyn G Dickinson,
Haroon Vohra (NMI),
Isabel Y Espinosa,
Jennifer D Hollstrom,
Jocelyn E Massey,
Joey V Quitania,
Jose M Cayuela,
Karen G Hirshfield,
Katherine E Jacobitz,
Kelvin Cheung,
Kimberley A Hoefen,
Linda M Cheny,
Mariza M Jafary,
Marlene G Swider,
Michael A Charles,
Michael E Maselli,
Michael J Kuchta,
Michael P Sheehan,
Michael R Goga,
Michael S Araneta,
Mra Narulaa,
Nancy G Schmidt,
Niketa Patel,
Omotunde O Osunsanmi,
Patricia A Brown,
Patricia A Cortez,
Patricia H Dlugosz,
Prabhu P Raju,
Roger F Zabinski,
Roger L Farmer,
Samir C Gala,
Sandra A Hughes,
Santiago Gallardo Johnson,
Santos E Camara,
Sean R Marcsisin,
Sidney B Priesmeyer,
Tara L Breckenridge,
Tara L Greene,
Torrance J Slayton,
Uttaniti Limchumroon (Tom),
Yong Wang,
Zachary A Bogorad,
Zachary L Miller,
Zachary L Stamm,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD
Steve Y Rhieu, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2019 | FDA 483 | Curia New Mexico, LLC - Form 483, 2019-03-15 |
March, 2019 | FDA 483 Response | Curia New Mexico, LLC - Form 483R, 2019-04-05 |
March, 2019 | EIR | Curia New Mexico, LLC - EIR, 2019-03-15 |
April, 2018 | FDA 483 | EyePoint Pharmaceuticals US, Inc. - Form 483, 2018-04-04 |
July, 2019 | FDA 483 | Baccinex SA - Form 483, 2019-07-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more